Endoplasmic reticulum (ER)-associated degradation (ERAD) represents a principle quality control mechanism to clear misfolded proteins in the ER; however, its physiological significance and the nature of endogenous ERAD substrates remain largely unexplored. Here we discover that IRE1α, the sensor of the unfolded protein response (UPR), is a bona fide substrate of the Sel1L-Hrd1 ERAD complex. ERAD-mediated IRE1α degradation occurs under basal conditions in a BiP-dependent manner, requires both the intramembrane hydrophilic residues of IRE1α and the lectin protein OS9, and is attenuated by ER stress. ERAD deficiency causes IRE1α protein stabilization, accumulation and mild activation both in vitro and in vivo. Although enterocyte-specific Sel1L-knockout mice (Sel1L ∆IEC ) are viable and seem normal, they are highly susceptible to experimental colitis and inflammation-associated dysbiosis, in an IRE1α-dependent but CHOP-independent manner. Hence, Sel1L-Hrd1 ERAD serves a distinct, essential function in restraint of IRE1α signalling in vivo by managing its protein turnover.
The endoplasmic reticulum (ER) is the principle site for the folding and quality control (QC) of proteins destined for the secretory pathway. Both physiological and pathological processes affect the workload in the ER. The imbalance of ER homeostasis often results in the aggregation of misfolded proteins in different cellular compartments, which are hallmarks of human diseases including cystic fibrosis, α1-antitrypsin deficiency and ageing. Misfolded proteins in the ER are mainly recognized and targeted for proteasomal degradation by the ER-associated degradation (ERAD) machinery 1, 2 . Identification of artificial proteins and disease-related mutant proteins as ERAD substrates has brought important insights into ERAD biology and the pathogenesis of ERAD-associated diseases, respectively 1 . However, our understanding of the importance of ERAD function under physiological settings is very limited because of the lack of animal models and physiologically relevant endogenous substrates.
Among several known mammalian ERAD complexes, the Sel1L-Hrd1 complex forms a principle ERAD machinery, responsible for the recognition and retrotranslocation of a subset of misfolded proteins in the ER for cytosolic proteasomal degradation [3] [4] [5] [6] [7] [8] [9] . Using inducible and adipocyte-specific Sel1L-deficient mouse and cell models, we recently provided in vivo evidence demonstrating that Sel1L is a key component of mammalian Hrd1 ERAD machinery and that the Sel1L-Hrd1 complex plays a critical role in the maintenance of ER homeostasis 10, 11 . Loss of Sel1L leads to a profound reduction of the Hrd1 protein level with a concomitant accumulation of a lectin protein OS9, pointing to an indispensable role of Sel1L in Hrd1 function 10, 11 . Intriguingly, loss of Sel1L in the pancreatic acinar cells causes exocrine (f) Western blot analysis of IRE1α in MEFs treated with 50 g ml −1 cycloheximide (CHX) for the indicated time, with quantification shown below. (g) Western blot analysis of IRE1α in CHX-treated WT and SEL1Ldeficient (SEL1L CRISPR ) HEK293T cells, with quantification shown on the right. The ERAD substrate OS9 and the cytosolic proteins BAG6 and HSP90 are shown as controls. Representative data from three independent experiments are shown. Unprocessed original scans of blots are shown in Supplementary Fig. 9 .
pancreatic insufficiency associated with significant cell atrophy 10 . In contrast, Sel1L deficiency in adipocytes has no obvious effect on cell death, but rather causes intracellular retention of lipoprotein lipase in the ER, leading to postprandial hypertriglyceridemia 11 . These intriguing findings point to a cell type-specific effect of Sel1L and Sel1L-Hrd1 ERAD as well as the significance of specific substrates in mediating the ERAD effect in vivo. Accumulation of misfolded proteins in the ER activates the unfolded protein response (UPR). IRE1α, the most conserved UPR sensor, is a type-1 transmembrane ER-resident protein with bifunctional cytosolic kinase and RNase domains. IRE1α is associated with the ER chaperone BiP (or GRP78) under basal conditions 12 . On sensing misfolded proteins in the ER, IRE1α dissociates from BiP, undergoes dimer-/oligomerization and trans-autophosphorylation through its kinase domain, which activates its RNase activity towards Xbp1 messenger RNA and leads to the generation of an active transcription factor XBP1s (refs [13] [14] [15] . XBP1s transcriptionally regulates the expression of many ER chaperone, lipogenic and ERAD genes 16 . Genetic studies have revealed that XBP1 is a risk factor for inflammatory bowel disease 17 (IBD) . In intestinal epitheliumspecific Xbp1-deficient mice, the IRE1α protein is hyperactivated, which promotes the development of IBD in part through the activation of JNK (refs 17,18) .
Here we report the discovery of IRE1α as a bona fide endogenous substrate of the Sel1L-Hrd1 ERAD complex both in vitro and in vivo, and elucidate underlying molecular mechanisms under both basal and stress conditions. Using intestinal epithelial-specific Sel1Ldeficient mice, we further demonstrate the pathological significance of ERAD-mediated IRE1α degradation in experimental colitis. Our data illustrate how the actions of ER QC systems, ERAD and UPR, are coordinated to cultivate a dynamic nature of ER homeostasis.
RESULTS
IRE1α is an endogenous ERAD substrate in vitro Acute loss of Sel1L in Sel1Lf/f;ERCre+ mouse embryonic fibroblasts (MEFs) treated with the tamoxifen analogue 4-OHT (Sel1L IKO ) leads to an ERAD defect 10 with dilated ER, when compared with that of Sel1Lf/f;ERCre+ MEFs treated with vehicle (WT; Fig. 1a ). In a search for endogenous Sel1L-Hrd1 substrates in the ER, we performed quantitative liquid chromatography with tandem mass spectrometry analysis of purified microsomal/ER fractions from Sel1L IKO and WT MEFs ( Supplementary Fig. 1a ), which identified a total of 3,220 proteins (Supplementary Table 1 ). Among many proteins overrepresented in Sel1L IKO MEFs were the lectin protein OS9, a known substrate of Sel1L-Hrd1 ERAD (refs 10,11) , and surprisingly, the UPR sensor IRE1α ( Supplementary Fig. 1b ). Western blot analysis of total cell lysates confirmed the accumulation of OS9 and IRE1α proteins in Sel1L IKO MEFs ( Supplementary Fig. 1c ). The elevated protein levels of IRE1α and OS9 were not due to increased transcription as the abundance of Ire1a and Os9 mRNA was actually reduced in Sel1L IKO MEFs ( Supplementary Fig. 1d ). Moreover, the IRE1α protein level, but not the other UPR sensor PERK, was negatively correlated with the levels of Sel1L and Hrd1 (Fig. 1b,c) . Excluding a nonspecific drug effect, 4-OHT treatment had no effect on the IRE1α protein level in f/f;ERCre− MEFs (Fig. 1d ). Pointing to a role of Hrd1 in IRE1α protein turnover, the IRE1α protein was stabilized and accumulated in Hrd1deficient MEFs (Fig. 1e,f and Supplementary Fig. 1e ).
To determine whether IRE1α ERAD is conserved in humans, we employed the CRISPR/Cas9-mediated knockout of SEL1L in human HEK293T cells. Endogenous IRE1α and OS9 proteins were greatly stabilized in SEL1L-deficient HEK293T cells, which was not seen for the cytosolic protein BAG6 (Fig. 1g ). In both Hrd1 −/− MEFs and SEL1L −/− HEK293T cells, IRE1α protein accumulation 
The role of OS9 and the intramembrane hydrophilic residues of IRE1α in Sel1L- was independent of transcriptional upregulation ( Supplementary  Fig. 1f ,g). Moreover, the IRE1α protein synthesis rate was comparable between WT and SEL1L −/− HEK293T cells as demonstrated by the 35 S-labelled methionine/cysteine incorporation assay ( Supplementary  Fig. 1h ). Thus, IRE1α is a substrate of SEL1L-HRD1 ERAD, conserved from mice to humans.
Substrate recognition by Sel1L-Hrd1 ERAD ERAD proceeds through four tightly coupled steps, substrate selection, retrotranslocation to the cytosol, ubiquitylation conjugation, and proteasomal degradation 2 . Hrd1 interacted with IRE1α and prompted IRE1α polyubiquitylation through its catalytic RING finger domain in transfected HEK293T cells ( Fig. 2a ). Sample denaturation before IRE1α immunoprecipitation confirmed ubiquitylation directly on IRE1α protein ( Supplementary Fig. 2a ). Consistent with the idea that disruption of the RING finger motif of Hrd1 prolongs the interaction with its substrate 19 , IRE1α interacted much more strongly with the catalytic inactive Hrd1 compared with WT Hrd1 (Fig. 2a ). Overexpression of Hrd1 partially reversed IRE1α accumulation in Sel1L IKO MEFs ( Fig. 2b and Supplementary  Fig. 2b ), suggesting that both Sel1L and Hrd1 are indispensable for IRE1α degradation. We next addressed how the Sel1L-Hrd1 ERAD complex identifies IRE1α as a potential ERAD substrate. OS9, a lectin protein, is known to recruit misfolded substrates, both glycosylated and non-glycosylated, to the Sel1L-Hrd1 ERAD complex 20, 21 . OS9 interacted strongly with IRE1α ( Supplementary Fig. 2c ). Deletion of OS9 increased IRE1α protein level and its stability ( Fig. 2c-e and Supplementary Fig. 2d,e ).
Inspired by the elegant work in yeast 22 , we explored the role of the intramembrane hydrophilic residues of IRE1α in its degradation. The transmembrane domain of IRE1α contains three hydrophilic amino acids (Thr 446, Ser 450, Thr 451), highly conserved from humans to fish ( Fig. 2f ). Mutating them to alanine (T446A, S450A and T451A, in short T3A) led to IRE1α protein accumulation and stabilization ( Fig. 2g -i). Indeed, the T3A mutation reduced IRE1α ubiquitylation and attenuated its interaction with Hrd1 ( Fig. 2j ), without affecting protein intracellular distribution or stress responsiveness ( Supplementary Fig. 2f ,g). Thus, both OS9 and the intramembrane hydrophilic residues of IRE1α may operate in parallel in ERAD-mediated IRE1α degradation.
The role of ER stress in IRE1α degradation MG132 treatment significantly increased IRE1α ubiquitylation ( Fig. 3a ), pointing to the involvement of proteasome in IRE1α degradation. Intriguingly, IRE1α ubiquitylation was reduced when challenged with the pharmacological ER stressor thapsigargin ( Fig. 3a and Supplementary Fig. 2h ). The effect of ER stress on IRE1α ubiquitylation was persistent even in the presence of MG132 ( Fig. 3a ), suggesting that ER stress affects IRE1α degradation upstream of protein ubiquitylation. Moreover, IRE1α interaction with Hrd1 and endogenous Sel1L was attenuated in response to ER stress (Fig. 3b,c) . IRE1α protein increased by nearly fivefold during ER stress in WT cells whereas only 1.5-fold in Sel1L IKO MEFs ( Supplementary Fig. 2i ), pointing to the contribution of IRE1α protein stabilization to its accumulation during ER stress. Indeed, IRE1α protein was markedly stabilized under ER stress ( Fig. 3d ). Hence, ER stress attenuates Sel1L-Hrd1-mediated IRE1α ubiquitylation and degradation. ER stress is triggered by the accumulation of misfolded proteins in the ER, and is known to initiate dimer-/oligomerization of IRE1α. To test whether misfolded proteins may compete with IRE1α for ERAD, we overexpressed a model ERAD substrate α1-antitrypsin variant null Hong Kong (NHK) in HEK293T cells. Indeed, model substrates interacted strongly with endogenous SEL1L and significantly attenuated the interaction between IRE1α and SEL1L ( Fig. 3e ). Moreover, ER stress induced dimer-/oligomerization of IRE1α protein as revealed by sucrose density gradient ultracentrifugation followed by non-reducing SDS-PAGE analyses ( Fig. 3f ) and was associated with increased resistance to trypsin digestion ( Fig. 3g ), pointing to a conformational change of IRE1α during ER stress. Thus, ER stress increases the level of ERAD substrates in the ER and triggers conformational change of IRE1α, both of which may contribute to the attenuated interaction between IRE1α and the ERAD complex.
The role of BiP in IRE1α degradation
BiP dissociates from IRE1α during ER stress ( Fig. 4a) 12 . Given the role of BiP in protein folding and degradation 23 , we next explored its role in IRE1α degradation. Cleavage of BiP with the subtilase cytotoxin SubAB (ref. 24 ) abolished the interaction between IRE1α and Sel1L (Fig. 4b ), reduced IRE1α ubiquitylation ( Supplementary   Fig. 2j ) and importantly, significantly stabilized IRE1α (Fig. 4c ). Conversely, ectopic expression of BiP attenuated the accumulation of IRE1α protein during ER stress ( Fig. 4d ), without affecting its mRNA level ( Supplementary Fig. 2k ). The effect of BiP overexpression on IRE1α protein level was seen only under the ER stress condition ( Fig. 4d ), consistent with the notion that BiP becomes limited and dissociates from IRE1α during ER stress 12 .
We next investigated ERAD degradation of a dimerizationincompetent IRE1α mutant 25, 26 . Mutation of IRE1α at the residue Asp 123 to Pro (D123P) rendered IRE1α largely irresponsive to ER stress as demonstrated by the lack of ER-stress-induced IRE1α phosphorylation ( Fig. 4e ). Unlike WT protein, D123P IRE1α interacted constitutively with endogenous BiP (Fig. 4e ) and failed to be stabilized under stress conditions ( Fig. 4f ). Hence, we conclude that BiP plays a key role in targeting IRE1α for ERAD degradation under basal conditions and that ER stress triggers BiP-IRE1α dissociation and dimer-/oligomerization of IRE1α, leading to IRE1α dissociation from the ERAD complex and protein stabilization ( Fig. 4g ).
IRE1α is an endogenous ERAD substrate in vivo
As dysregulated IRE1α signalling in intestinal epithelium has been implicated in the pathogenesis of IBD (refs 17,18), we generated intestinal epithelial cell (IEC)-specific Sel1L-deficient mice (Sel1L ∆IEC ). Sel1L ∆IEC and Sel1L flox/flox (WT) control littermates were born at the expected Mendelian ratios ( Supplementary Fig. 3a ) and grew at comparable rates for both females and males ( Fig. 5a ). Both Sel1L and Hrd1 protein levels were significantly reduced in the gut of Sel1L ∆IEC mice (Fig. 5b,c) . These mice were deficient for epithelial ERAD function as demonstrated by the accumulation of the OS9 protein ( Fig. 5b ,c).
The IRE1α protein level was elevated by over 15-fold in the colonic epithelium of Sel1L ∆IEC mice (Fig. 5b ,c), but its mRNA level was not altered (Fig. 5d ). The accumulation of both IRE1α and OS9 proteins in the colonic epithelium was confirmed by immunohistochemistry ( Fig. 5e and Supplementary Fig. 3b ). To argue against developmental defects as a possible cause for IRE1α accumulation in Sel1L ∆IEC mice, acute loss of either Sel1L or Hrd1 caused a significant accumulation of the IRE1α protein without affecting its mRNA level ( Fig. 5f -i). Further supporting the notion that epithelial IRE1α is an ERAD substrate, the IRE1α protein was highly stabilized in primary intestinal crypt organoids from Sel1L ∆IEC mice ( Fig. 5j,k) . In contrast, ERAD deficiency had no effect on the protein or mRNA levels of the IRE1α homologue IRE1β ( Supplementary Fig. 3c ), despite a ∼50% identity in amino acid sequences. Of note, three intramembrane hydrophilic residues were not conserved between IRE1α and IRE1β proteins ( Supplementary Fig. 3d ).
We next tested whether Sel1L-Hrd1-mediated IRE1α degradation is a general phenomenon. The IRE1α protein level was highly elevated in the pancreas of Sel1L IKO mice at day 4 and 8 posttamoxifen injection 10 (Supplementary Fig. 3e ) and white adipose tissue of adipocyte-specific Sel1L-deficient (AKO or Sel1L ∆adipo ) mice 11 ( Supplementary Fig. 3f ). The Ire1a mRNA level was not affected by Sel1L deficiency ( Supplementary Fig. 3g and not shown). IRE1α protein was significantly stabilized in Sel1L ∆adipo primary adipocytes ( Fig. 5l ). Taken together, our data demonstrate that IRE1α is a bona fide endogenous ERAD substrate in vivo.
A regulatory circuit of IRE1α and Sel1L-Hrd1
In both yeast and mammalian cells, the IRE1α signalling pathway regulates the expression of ERAD components 15 . We next performed both gain-and loss-of-function studies to determine whether this is true in enterocytes. Overexpression of XBP1s in small intestinal crypt m-IC cl2 enterocytes increased the expression of Sel1L, Hrd1 and Os9 ( Supplementary Fig. 4a ). Conversely, knockout of IRE1α or XBP1 in m-IC cl2 enterocytes attenuated the expression of ERAD components including Sel1L, Hrd1 and Os9 ( Supplementary Fig. 4b,c ). Thus, our data establish a negative regulatory circuit consisting of IRE1α-XBP1 and the Sel1L-Hrd1 ERAD in enterocytes ( Supplementary Fig. 4d ).
Restraint of IRE1α signalling by ERAD
In Sel1L ∆IEC enterocytes, IRE1α was hyperphosphorylated and activated as measured by mobility shift of phosphorylated IRE1α protein [27] [28] [29] and Xbp1 mRNA splicing ( Fig. 6a-c) . Similar observations were obtained in other models with acute or chronic Sel1L deficiency, including Sel1L IKO MEFs (Fig. 6d,e ), pancreas ( Supplementary  Fig. 3e ), ileum ( Supplementary Fig. 4e ) and Sel1L ∆adipo adipose tissue ( Supplementary Fig. 4f ,g). Without Sel1L, accumulated IRE1α proteins, including phosphorylated IRE1α, did not form NP-40-insoluble aggregates in the epithelium ( Fig. 6f ) and were highly responsive to ER stress ( Fig. 6g,h) . Consistently, the Xbp1s mRNA level was much higher in Sel1L-deficient adipocytes when treated with thapsigargin ( Fig. 6i ). Moreover, crypt organoids isolated from Sel1L ∆IEC mice exhibited elevated JNK phosphorylation in response to TNFα stimulation ( Fig. 6j) . Similarly, knockdown of Sel1L in enterocytes elevated TNFα-induced JNK phosphorylation ( Supplementary Fig. 4h -j) and Tnfa expression ( Fig. 6k ). Therefore, Sel1L-Hrd1 ERAD restrains IRE1α signalling and attenuates IRE1αassociated inflammation, at least in part, through ERAD-mediated IRE1α degradation.
Sensitivity to experimental colitis
To our surprise, the length and gross morphology of the colon of Sel1L ∆IEC mice seemed normal, indistinguishable from those of WT littermates under basal conditions ( Fig. 7a and Supplementary Fig. 5a ). There was no increase of cell death or signs of spontaneous colitis in the colonic epithelium of Sel1L ∆IEC mice ( Fig. 7a,b ). Genome-wide microarray analysis of colonic epithelium revealed that inflammation and cell death pathways were not upregulated in Sel1L ∆IEC mice under basal conditions (Supplementary Table 2 ). In keeping with elevated IRE1α signalling ( Fig. 6 ), top upregulated pathways identified by the microarray were the 'protein processing in the ER' , 'UPR' and 'activation of ER chaperones by IRE1α' (Supplementary Fig. 5b ). Genes involved in UPR and ERAD such as Derlin 3, Pdia6, Trib3, and BiP were among the top genes induced in the epithelium of Sel1L ∆IEC mice when compared with WT littermates ( Supplementary Fig. 5c and Supplementary Table 3 ).
Treatment with dextran sodium sulphate (DSS) induces epithelial TNFα signalling and triggers epithelial injury and colitis, a widely used model to study disease pathogenesis of IBD (ref. 30) . Indeed, colonic epithelia of Sel1L ∆IEC mice exhibited a significant increase of cell death following DSS challenge (Fig. 7c,d and Supplementary Fig. 5d ). Sel1L ∆IEC mice developed more severe clinical signs of mucosal inflammation and colitis, including body weight loss ( Fig. 7e ), gross rectal bleeding and diarrhoea ( Supplementary Fig. 5e ). Most Sel1L ∆IEC mice (∼90%) succumbed to DSS treatment by day 12 (Fig. 7f ). Colon shortening, a typical clinical feature of colonic inflammation, was more pronounced in Sel1L ∆IEC mice ( Fig. 7g ). Histological examination of the distal colon of Sel1L ∆IEC mice revealed a near complete loss of epithelium and crypts, increased colonic mucosal damage/erosion, massive immune cell infiltration and lymphoid foci formation, and oedema ( Fig. 7h ,i). The difference in colitis sensitivity was not due to variable DSS intake ( Supplementary Fig. 5f ). DSS-induced colitis and lethality were prevented by coadministration of broad-spectrum antibiotics in the drinking water ( Fig. 7f ). Fluorescence in situ hybridization (FISH) analysis of Eubacteria demonstrated more severe bacterial invasion of the colonic mucosa of DSS-treated Sel1L ∆IEC mice. Patchy bacterial invasion into the epithelium, thick mats of superficial invasive bacteria associated with diffuse ulceration and intraluminal bacterial proliferation in epithelial cell debris were commonly observed in the Sel1L ∆IEC samples ( Supplementary Fig. 5g ). Interestingly, although not commonly present in the colon under basal conditions, invasive Escherichia coli were observed on and within colonic mucosa of Sel1L ∆IEC mice (panel 1, Fig. 7j ), or associated with dead cells sloughed off the epithelium (panel 2, Fig. 7j ). Adherent and invasive E. coli has been previously associated with pathogenesis of human Crohn's disease and murine ileitis 31 . Gut microbial composition was expectedly very similar in co-housed WT and Sel1L ∆IEC mice under basal conditions ( Supplementary Fig. 5h ), with Enterobacteriaceae including the family of E. coli barely detectable in the faeces of both cohorts (not shown). Thus, intestinal inflammation may drive E. colidominated dysbiosis and bacterial invasion as previously reported 32 .
In keeping with increased invasive and adherent bacteria in the colonic epithelium of DSS-treated Sel1L ∆IEC mice, activated CD8 + T cells were elevated in the spleen and mesenteric lymph nodes ( Supplementary Fig. 5i ). Inflammatory cytokines that have been linked to endotoxemia and sepsis 33 , including macrophage inflammatory protein 2 (MIP2), granulocyte-colony stimulating factor (G-CSF) and platelet-derived growth factor β polypeptide (PDGF-BB), were significantly increased in the circulation of DSStreated Sel1L ∆IEC mice ( Supplementary Fig. 5j ). A similar trend was observed for IL-1β, TNFα and IL-6, albeit this was not statistically significant. These data point to a severe systemic pro-inflammatory response in DSS-treated Sel1L ∆IEC mice. In the aggregate, Sel1L is dispensable for the gross morphology of the colon, but its deficiency sensitizes the animal to experimental colitis and inflammationinduced dysbiosis.
Pathological significance of IRE1α degradation
To determine whether IRE1α accumulation modulates the pathogenesis of experimental colitis, we generated Sel1L ∆IEC mice with only one copy of the epithelial Ire1a gene (Sel1L ∆IEC ;Ire1a +/− ; Supplementary Fig. 6a ,b) and subjected them, together with three other control cohorts, to DSS-induced colitis. Sel1L ∆IEC ;Ire1a +/− mice were less sensitive to DSS-induced colitis, with ameliorated body weight loss and colon shortening when compared with that of DSS-treated Sel1L ∆IEC mice (Fig. 8a,b ). Histological assessment revealed attenuated colonic damage in DSS-treated Sel1L ∆IEC ;Ire1a +/− mice compared with that of Sel1L ∆IEC mice (Fig. 8c) . The IRE1α protein level in the epithelium of Sel1L ∆IEC ;Ire1a +/− mice was 6-8-fold less than that of Sel1L ∆IEC mice, but remained 3-fold more than that of WT mice (Fig. 8d ). BiP levels, both mRNA and protein, were not affected by IRE1α heterozygosity in Sel1L ∆IEC mice (Fig. 8d,e ). Moreover, treatment with a JNK-specific inhibitor SP600125 attenuated inflammation and ameliorated DSS sensitivity of Sel1L ∆IEC mice ( Supplementary Fig. 6c-f ). Both protein and mRNA levels of PERK were elevated in the gut epithelium of Sel1L ∆IEC mice ( Supplementary Fig. 7a,b) , independently of IRE1α protein levels ( Supplementary Fig. 7c ), and so was its downstream target CHOP ( Fig. 8f and Supplementary  Fig. 7d ). To determine the role of the PERK-CHOP axis in disease pathogenesis, we generated Sel1L ∆IEC mice on the Chop −/− background (Sel1L ∆IEC ;Chop −/− ) ( Supplementary Fig. 7e ). Loss of Chop in Sel1L ∆IEC mice had no effect on the IRE1α protein level and its phosphorylation ( Supplementary Fig. 7f-h) . To our surprise, we found no evidence for a possible role of Chop in hypersensitivity to experimental colitis of Sel1L ∆IEC mice, in terms of body weight, colon length and lesions ( Fig. 8g-i) . Hence, IRE1α accumulation, but not CHOP, contributes directly to inflammation and the pathogenesis of experimental colitis in Sel1L ∆IEC mice.
Lack of haploinsufficiency of Sel1L in vivo
Last, we generated Sel1L ∆IEC/+ (HET) mice as littermates to WT and Sel1L ∆IEC mice ( Supplementary Fig. 8a,b ). Sel1L ∆IEC/+ mice were indistinguishable from their WT littermates, in terms of the IRE1α protein level, ER stress, and sensitivity to experimental colitis ( Supplementary Fig. 8c-h) . As Sel1L ∆IEC/+ mice express the Cre recombinase, these data excluded a possible effect of the Cre recombinase in the disease pathogenesis of Sel1L ∆IEC mice. Thus, one copy of Sel1L in enterocytes is sufficient for ERAD function, IRE1α degradation and colon homeostasis.
DISCUSSION
Both UPR and ERAD are evolutionarily conserved QC systems in the cell, whose coordinated activities are essential for the maintenance of ER homeostasis. However, how they are coordinated remains poorly understood. Here our data establish ERAD-mediated IRE1α protein turnover as a general self-regulatory mechanism within the ER QC systems that occurs in many cell types, both in vitro and in vivo, and is conserved from mice to humans. This study fills an important gap in the QC mechanisms by demonstrating an ingenious built-in system of 'checks and balances' to dynamically fine-tune the IRE1α protein level, and thereby its activity and ER folding and degradation capacity, in response to dynamic fluctuation of ER homeostasis. Using an acute injury model, we further establish that ERAD-mediated IRE1α degradation is an important regulatory mechanism in restraining IRE1α signalling in enterocytes in the pathogenesis of experimental colitis in vivo (Fig. 8j) .
Similar to the case of HMG-CoA reductase (HMGCR) where its degradation is highly responsive to host physiology 3, 34 , our data demonstrate that IRE1α degradation by ERAD is highly responsive to ER homeostasis (Fig. 4g ). IRE1α interacts with and is ubiquitylated by the Sel1L-Hrd1 ERAD core complex under basal conditions. The selection of IRE1α for degradation may involve BiP and OS9 as well as the intramembrane hydrophilic residues of IRE1α. ER stress triggers IRE1α-ERAD complex dissociation and hence attenuates IRE1α ubiquitylation, which coincides with IRE1α dimer-/oligomerization and activation. Our data show that the key player involved in the ER-stress-mediated regulation of IRE1α protein turnover is likely to be BiP. BiP is indispensable for IRE1α degradation as depletion of BiP leads to the dissociation between IRE1α and ERAD and hence IRE1α protein stabilization whereas overexpression of BiP had the opposite effect. Providing further support to the key role of BiP in IRE1α degradation, the dimerization-defective D123P IRE1α mutant associates constitutively with BiP and has a shorter half-life than that of WT IRE1α under stress conditions. Collectively, our data show that BiP plays a key role in targeting IRE1α for ERAD degradation under basal conditions and that ER stress triggers BiP dissociation from IRE1α and dimer-/oligomerization of IRE1α, leading to the IRE1α-ERAD complex dissociation and IRE1α protein stabilization. Hence, BiP restrains IRE1α signalling under basal conditions not only by sequestering IRE1α in an inactive state, but also by targeting it for ERAD. This finding is consistent with the known role of BiP in substrate recruitment in ERAD (refs [35] [36] [37] [38] [39] .
As Sel1L-Hrd1 ERAD deficiency is intrinsically associated with the accumulation of misfolded proteins in general and hence ER stress, it may follow that the phenotypes of Sel1L ∆IEC mice are a result of ER stress. Recent studies have also supported the role of ER stress in the pathogenesis of spontaneous and experimental colitis 17, 18, 40, 41 . In the absence of Sel1L, ER stress is moderately induced but well tolerated by the colonic epithelium as the Sel1L ∆IEC mice are surprisingly asymptomatic under basal conditions. The morphology of colonic epithelium and goblet cells-the major secretory cell type in the colon-seems largely normal. Thus, moderate ER stress associated with Sel1L-Hrd1 ERAD deficiency is not sufficient to alter normal physiology in the colon and induce spontaneous colitis under basal conditions. Nonetheless, Sel1L ∆IEC mice are more susceptible to DSS-induced experimental colitis in an IRE1α-dependent and Chop-independent manner. Thus, our study reveals the pathological importance of gut epithelial Sel1L-Hrd1 ERAD and the regulation of the IRE1α protein turnover in vivo. Although Sel1L-Hrd1 ERAD is likely to have other substrates in colonic epithelium, these findings provide strong support for the notion that IRE1α degradation by ERAD is pathologically significant. This regulatory mechanism may be of great therapeutic importance as IRE1α signalling may play a critical role in intestinal inflammation 17, 18 .
METHODS

Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper DOI: 10.1038/ncb3266 METHODS Mice. Sel1L ∆IEC , Sel1L ∆IEC/+ , Sel1L ∆IEC ;Ire1a +/− , Sel1L ∆IEC ;Chop −/− , inducible Sel1L KO (Sel1L IKO ) and inducible Hrd1 KO (Hrd1 −/− ) mice were used in this study. Sel1L flox/flox , Sel1L ∆adipo , Hrd1 flox/flox and Ire1a flox/flox mice were described previously 10, 11, 42, 43 . Sel1L IKO and inducible Hrd1 KO mice were generated using intraperitoneal injection of tamoxifen as previously described 10 . Sel1L flox/flox mice were crossed with villin-1 promoter-driven Cre mice (B6.SJL-Tg(Vil-cre)997Gum/J, JAX 004586). Different breeding schemes are shown in Supplementary Figs 3a, 6a and 8a. In addition, Sel1L ∆IEC mice were crossed with Chop −/− mice (B6.129S(Cg)-Ddit3 tm2.1Dron /J, JAX 005530) to generate Sel1L flox/flox ;VillinCre + ;Chop −/− double knockout (EKO;Chop −/− ) mice. Mice were housed under specific pathogen-free conditions and fed on a low-fat diet consisting of 13% fat, 67% carbohydrate and 20% protein (Harlan Teklad 2914). Co-housed age-matched adult littermates were used at the age of 6-12 weeks in all in vivo experiments. Animal euthanasia was performed by cervical dislocation. Tissues were immediately collected and either fixed in 10% neutralized formalin for histology or snap-frozen in liquid nitrogen for protein and RNA analyses. Frozen tissues were stored at −80 • C.
Based on the sample size formula of the power analysis, N = 8(CV) 2 [1+(1-PC) 2 ]/(PC) 2 , to reach the error = 0.05, power = 0.80, percentage change in means (PC) = 20%, coefficient of variation (CV) = 10-15% (varies between the experiments), 5 mice per group are the minimal number to obtain statistical significance. Mice in each group were randomly chosen on the basis of the age, genotype and gender. All animal procedures have been approved by the Institutional Animal Care and Use Committee (IACUC) at Cornell and Northwestern universities.
Cell lines. Sel1L flox/flox ;ERCre + MEFs were generated and Se11L deletion was induced by treatment with 400 nM 4-hydroxytamoxifen (4-OHT, Sigma H7904) as previously described 10 . In some studies, parental Sel1L flox/flox ;ERCre + MEFs were transfected to stably express pcDNA3-His-Myc-HRD1 using Lipofectamine 2000 (Invitrogen) as per the supplier's protocol. Twenty-four hours later, cells were selected with 400 µg ml −1 G418 (EMD Millipore) and G418-resistant cells were expanded for further analysis. These cells were treated with 4-OHT or vehicle as described above to delete Sel1L. Hrd1 −/− and WT MEFs were provided by T. Nakajima (Tokyo Medical University) 44 . IRE1α −/− MEFs stably expressing pMSCV-hIRE1α-HA (WT or D123P mutant) were previously described 26 . All cells including HEK293T and MEFs were maintained in DMEM (Cellgro) supplemented with 10% FBS (Sigma) and 1% penicillin-streptomycin (Cellgro). Mouse intestinal m-IC cl2 cells were a gift from J. Appleton (Cornell University, USA) and were cultured as previously described 45 . For stable shRNA knockdown, Sel1L and Hrd1 shRNA targeting sequences (5 -GGTTACACTGTGGCTA GAA-3 and 5 -GGAGAGTTTCAGATGATTA-3 ) were cloned into pSuper/retro vector (H1 promoter). Control RNAi was against the firefly luciferase 27 . m-IC cl2 cells stably expressing XBP1s were generated using retroviral transduction as previously described 27 . MEFs expressing BiP-or control LacZ were generated using adenoviral infection at 1,000 multiplicity of infection (MOI) per well of a 6-well plate (adenoviruses were provided by H. Lob and R. Davisson at Cornell University, USA). Four days after infection, cells were treated with 300 nM thapsigargin for 12 h and snap-frozen for western blotting.
CRISPR-based knockout cell lines. CRISPR targeting oligonucleotides designed
for human SEL1L (no. 1 5 -ACTGCAGGCAGAGTAGTTGC-3 , no. 2 5 -GACAT CAGATGAGTCAGTAA-3 ) and human OS9 (5 -GCAAGTCTGACCGGCGGT GTC-3 ) were inserted into the pX330-U6-Chimeric_BB-CBh-hSpCas9 vector (Addgene 42230). Oligonucleotides targeting mouse Xbp1 (5 -GCTCATGGTACCC GGTCCGC-3 ) and mouse Ire1α (5 -CTTGTTGTTTGTCTCGACCC-3 ) were used in m-ICc12 cells. Cells were co-transfected with CRISPR constructs, together with the pBabe-puro vector, and selected with 2 or 3 g ml −1 puromycin (Invitrogen) for 48 h. Surviving cells were plated to 96-well plates with one cell per well for singlecolony selection. Knockout efficiency in HEK293T cells was assessed by western blot analysis. In m-ICc12 cells, knockout lines were sequenced using primer sets 5 -GC CCCCAAAGTGCTACTCTTA-3 and 5 -CCGTGAGTTTTCTCCCGTAA-3 for Xbp1 and 5 -TTTTGGAAGAACCAGCACAG-3 and 5 -GCCAGTCAGGAGGTC GATAA-3 for Ire1α.
Transmission electron microscopy. Sel1L flox/flox ;ERCre + MEFs were treated with vehicle (WT) or 4-OHT (Sel1L IKO ) for 3 days, collected and fixed. Samples were stained, dehydrated, and processed as described before 10 .
ER purification and precipitation. ER purification was performed as previously described 46 . Briefly, Sel1L flox/flox ;ERCre + MEFs were treated with 4-OHT or vehicle for 4 days. Subsequent steps were performed at 4 • C in the presence of the protease inhibitor cocktail (Sigma). A total of 1 × 10 7 cells were homogenized in a Dounce grinder with buffer A (50 mM Tris-HCl pH 8.0, 1 mM β-mercaptoethanol, 1 mM EDTA, and 0.32 M sucrose), and then centrifuged at 5,000g for 10 min. The supernatant was centrifuged at 105,000g for 1 h (XL-80K, Beckman). The pellet was disrupted in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM dithiothreitol, 1 mM sodium orthovanadate and 10 mM sodium fluoride) followed by centrifugation at 15,000g for 20 min. The resulting supernatant, the ER fraction, was quantified using the Bradford assay and adjusted to the same protein concentration. A 200 µl ER fraction was precipitated by methanol and chloroform and subjected to mass spectrometric analysis.
Mass spectrometry. Mass spectrometry to identify ERAD substrates was performed as previously described 47 .
Protein lysate preparation, western blot and quantification. Preparation of cell and tissue lysates and western blotting were performed as previously described 27 . IRE1α phosphorylation was measured by a Phos-tag-based western blot method [27] [28] [29] . For non-reducing SDS-PAGE, lysates were prepared in 5× non-denaturing sample buffer (250 mM Tris-HCl pH 6.8, 1% SDS, 50% glycerol and 0.05% bromophenyl blue) without boiling before being separated on an SDS-PAGE gel. Antibodies used in this study were: HSP90 (sc-7947, 1:6,000), GFP (sc-8334, 1:2,000), BiP (sc-1051, 1:1,000), IRE1β (sc-20575, 1:1,000), JNK1 (sc-571, 1:1,000), α-tubulin (sc-5286, 1:2,000) from Santa Cruz; IRE1α (no. 3294, 1:2,000), PERK (no. 3192, 1:2,000), caspase-3 (no. 9665, 1:1,000), p-T183/Y185-JNK (no. 9255, 1:2,000), from Cell Signaling; Sel1L (ab78298, 1:2,000), OS9 (ab109510, 1:10,000) from Abcam; Hrd1 (NB100-2526, 1:8,000) from Novus Biologicals; calnexin (SPA-860, 1:8,000) and PDIA1 (SPA-890, 1:8,000) from Enzo Life Sciences; Flag-HRP (A-8592, 1:8,000), HA (H9658, 1:5,000) from Sigma. Antibodies for Bag6 (rabbit, 1:10,000) and H2A (rabbit, 1:10,000) were gifts from Y. Ye (NIDDK, USA). Band density was quantified using the Image Lab software on the ChemiDOC XRS + system (Bio-Rad). Protein levels were normalized to HSP90 or α-tubulin and are presented as mean ± s.e.m. unless otherwise specified.
Immunoprecipitation (IP). Cells were lysed in lysis buffer (150 mM NaCl, 1 mM EDTA, 50 mM Tris-HCl pH 7.5 or 8.0, protease inhibitor and protein phosphatase inhibitor and 10 mM N -ethymaleimide) supplemented with 1% Triton X-100 or 1% Nonidet P-40 (NP-40). A total of ∼2 mg protein lysates was incubated with 2 µl primary or irrelevant antibody overnight at 4 • C with gentle rocking. Antibodies used for IP: IRE1α (Cell Signaling, no. 3294), GFP (Santa Cruz, sc-8334), and normal rabbit IgG (Santa Cruz, sc-2027). Immunocomplexes were precipitated with protein A-agarose beads (Invitrogen, 15918014) for 8 h at 4 • C, washed and eluted by boiling for 5 min in ×2 SDS sample buffer. For immunoprecipitation of tagged proteins, lysates were immunoprecipitated overnight at 4 • C with HA-(Sigma, A2095) or FLAG-agarose beads (Sigma, A2220). For denaturing IP, HEK293T cells transfected with indicated plasmids in each 10 cm dish were lysed in 200 µl NP-40 lysis buffer with 1% SDS and 5 mM dithiothreitol, and denatured at 95 • C for 10 min. Subsequently, samples were diluted 1:10 with NP-40 lysis buffer followed by IP as described above.
Substrate competition. HEK293FT cells were transfected with empty vector or
pEGFP-N1 plasmid (Clontech) containing NHK-GFP using Lipofectamine 2000 (Invitrogen) as per the manufacturer's instructions. Two days after transfection, cells were snap-frozen in liquid nitrogen. IP was carried out as described above.
In vitro drug treatment. Thapsigargin (Tg), tunicamycin (Tm) and MG132 were purchased from Millipore, dissolved in dimethylsulphoxide and used at 150-300 nM, 2.5 µg ml −1 , and 10 µM, respectively. Cycloheximide (CHX, Millipore) was dissolved in ethanol and used at 50 µg ml −1 . To evaluate inflammatory responses, cells were treated with 50 ng ml −1 murine TNFα for 10 min with or without 1 h pretreatment with 50 µM SP600125 (ref. 48 ). SubAB and its catalytic inactive mutant form SubA A272 B were used at 1 µg ml −1 as previously described 24 .
Plasmids. The following plasmids were used (h denotes human genes; m denotes mouse genes): pCMV-Tag4A-hIRE1α-Flag (gift from Y. Liu, Institute of Nutritional Sciences, China) 49 ; pcDNA3-His-Myc-hHrd1 WT and RING finger mutant C2A (C291A/C294A) (gifts from Y. Ye, NIDDK, USA) 19 ; pcDNA3-HA-Ub and pcDNA3-HA-hSel1L (gifts from H. Nishitoh, University of Miyazaki, Japan). IRE1α T3A mutants (T446A, S450A and T451A) were generated using site-directed mutagenesis of pCMV-Tag4A-hIRE1α-Flag and mutagenesis primers are Forward: 5 -CTTAAG GACATGGCTGCCATCATCCTGGCCGCCTTCCTGCTGATTG-3 , Reverse 5 -C AATCAGCAGGAAGGCGGCCAGGATGATGGCAGCCATGTCCTTAAG-3 .
Sucrose gradient sedimentation analysis. Confluent WT MEFs in two 10 cm plates either mock-treated or treated with 300 nM Tg for 4 h were lysed in 0.5 ml 1% NP40 lysis buffer. Extracts were centrifuged through 20%-40% sucrose gradients (in 150 mM NaCl, 1 mM EDTA, 50 mM Tris-HCl pH 7.5 and protease inhibitor) prepared freshly by progressively layering higher to lower density sucrose fractions in 5% increments. Extracts were centrifuged at 58,000 r.p.m. for 14.5 h at 4 • C using an SW 60 Ti rotor (Beckman Coulter). Each 4 ml gradient was divided evenly into 10 fractions (400 µl each), and aliquots of fractions 5-10 were subjected to western blot analyses under denaturing or non-denaturing conditions. Limited proteolysis. HEK293T cells were incubated in the absence or presence of 100 nM Tg for 3 h, collected, and lysed in lysis buffer containing 50 mM HEPES (pH = 7.5), 150 mM NaCl and 1% Triton X-100 on ice for 15 min. Aliquots of the lysates were mixed with various concentrations of trypsin and incubated on ice for 30 min. Reaction was quenched by adding SDS sample buffer and immediately heated at 95 • C for 10 min followed by western blot analysis.
Pulse labelling and pulse-chase analysis. Cells transfected with Flag-IRE1α or HA-IRE1α were cultured with cysteine-and methionine-free medium (Invitrogen, 21013024) containing 10 mM HEPES, pH 7.4 at 37 • C for 30 min and pulse labelled with 100 µCi ml −1 [ 35 S]-cysteine and methionine (EasyTag, PerkinElmer) at 37 • C for 30 min. In the pulse-chase assay, following a 30 min pulse, cells were cultured in chase medium (10 mM HEPES, 5 mM cysteine, 5 mM methionine) for the indicated time in the presence or absence of 300 nM Tg. Cells were then extensively washed with ice-cold HBSS buffer (Gibco, Life Technologies) and snap-frozen in liquid nitrogen. Cells were lysed and immunoprecipitated as described above using NP-40 as detergent. Lysates were separated on a 7% SDS-PAGE gel, which was subsequently incubated with the neutralizing buffer (30% (v/v) methanol in PBS) for 10 min followed by the enhancer buffer (1.5 M sodium salicylate (Sigma) in 30% (v/v) methanol) for 10 min. The gel was then dried at 80 • C for 2 h using a gel drier (Model 583, Bio-Rad) and subjected to autoradiography with X-film (Kodak).
Histological analysis. Tissues were fixed in 10% neutralized formalin and processed by the Cornell Histology Core Facility on a fee-for-service basis. Haematoxylin and eosin (H&E) slides were photographed as previously described 10 . Tissue sections were examined blindly by a board-certified anatomic pathologist (G.E.D.). For the assessment of the severity of experimental colitis, histological scores of the distal colon were blindly determined based on globet cell loss, crypt abscesses, immune cell infiltration and epithelial erosion (0, none; 1, low; 2, moderate; 3, high; 4, maximal) as previously described 50 . Of note, other animal experiments were not performed blindly.
Animal experiments. High-throughput sequencing of 16S rRNA V4 region of faecal pellets from co-housed 8-week-old mice was performed as previously described 51 . Mice were fed ad libitum with 3% (wt/vol) DSS (relative molecular mass 40,000-50,000; Affymetrix) dissolved in drinking water for 5 days and then fresh water thereafter. Body weights were monitored every other day until the end of experiments. Stool consistency (0, normal; 1, soft but still formed; 2, very soft; 3, diarrhoea) and stool blood (0, negative; 1, positive haemoccult; 2, blood traces in stool visible; 3, rectal bleeding) were assessed on day 6 after DSS treatment started 50 . At day 7, flow cytometric analysis of activated CD8+ T cells was performed as previously described 52 and serum cytokine levels were measured using the Bio-Plex Pro Mouse Cytokine 9-and 23-plex Assay and the Bio-Plex MAGPIX system (Bio-Rad no. M6009RDPD) as per the manufacturer's instructions. For antibiotic treatment, mice were given ampicillin (1 g l −1 ; Fisher) and neomycin sulphate (1 g l −1 ; Cellgro) dissolved in drinking water during and after DSS treatment. For humane reasons and IACUC guidelines, mice were declared 'dead' and were euthanized when their body weight dropped by 20%. SP600125 (LC Laboratories), a JNK-specific inhibitor 48 , was dissolved in 7% Kolliphor Solutol HS-15 (Sigma, in PBS) at 3 mg ml −1 . Age-matched littermates were injected intraperitoneally with SP600125 or vehicle at a volume of 10 µl g −1 body weight every other day with a concurrent 5-day 3% DSS feeding regimen until the end of the experiment. Mice were monitored daily and body weights were measured every other day.
Colonic epithelium isolation. After removing surrounding fat and connective tissues, the colon was cut longitudinally into small pieces and shaken in 5 ml PBS containing 30 mM EDTA at 37 • C for 20 min. Colonic epithelial cells were released by vortexing at max setting for 15 s twice and collected from supernatant. Purified cells were used for protein, mRNA and microarray analyses. The purity of colonic epithelial cells was examined using RT-PCR analysis of the enterocyte-specific gene villin and the leukocyte-specific gene CD45.
Organoid culture. Small intestine crypts were isolated and cultured as described previously 53 . Briefly, small intestines from adult mice were rinsed with ice-cold PBS, cut longitudinally and shaken vigorously in ice-cold PBS to remove villi. Tissues were cut into small pieces and shaken gently in 30 ml PBS containing 2 mM EDTA at 4 • C for 1 h. Crypts were released by vigorous shaking and were pelleted at 230 rcf for 2 min at 4 • C. Isolated crypts were mixed with Matrigel (Corning), plated in 24-well plates, and cultured in crypt culture medium (Advanced DMEM/F12, Invitrogen) containing growth factors (50 ng ml −1 EGF (Invitrogen), 500 ng ml −1 R-spondin-1 (R&D) and 100 ng ml −1 Noggin (Peprotech)). For drug treatment, organoids were either treated with 25 µg ml −1 CHX for 2 h or 50 ng ml −1 murine TNFα for 20 min, then removed from Matrigel mechanically in ice-cold PBS and pelleted immediately for protein or RNA extraction.
Immunohistochemistry (IHC). Formalin-fixed, paraffin-embedded intestinal sections were processed for IHC and TUNEL staining as previously described 10 . IHC was performed with the Histostain kit and DAB substrate from Invitrogen. Primary antibodies used for IHC were IRE1α (no. 3294, 1:100) from Cell Signaling and OS9 (ab109510, 1:200) from Abcam. Sections were scanned and images were taken using the Aperio Scanscope. TUNEL staining was performed with the in Situ Death Detection TUNEL Kit (Roche 11684795910). The fluorescence was visualized and images were captured under a Zeiss LSM710 confocal microscope with ×10 magnification at Cornell Biotechnology Resource Center Imaging Facility.
FISH. Formalin-fixed paraffin-embedded intestine sections were mounted on
Probe-On Plus slides (Fisher) and evaluated by FISH with probes to all bacteria (EUB338-5'Cy3) or E. coli/Shigella (E. coli-5'Cy3, 16S rRNA), in combination with a nonspecific binding control probe (non-EUB338-5 FAM) (IDT), as previously described 32 . Sections were examined with an Olympus BX51 fluorescence microscope and images were captured with an Olympus DP-7 camera.
Immunofluorescent staining. HEK293T cells were plated on poly-L-lysine-coated coverslips and transfected with Flag-IRE1α WT or T3A mutant plasmids for 24 h. Cells were processed and labelled with anti-IRE1α (#3294, Cell Signaling) and anti-BiP (sc-1051, Santa Cruz) as previously described 47 . Cells were then labelled with donkey anti-rabbit AF594 (711-585-152) and donkey anti-goat AF680 (705-625-147) from Jackson ImmunoResearch, and mounted with Prolong Gold Antifade Reagent with DAPI (Invitrogen). Fluorescent microscopic images were taken under a Zeiss LSM710 confocal microscope at Cornell Biotechnology Resource Center Imaging Facility.
NP-40 solubility assay. Frozen terminal ileum tissue was weighed and
homogenized in NP-40 lysis buffer as previously described 10 . The lysate volume was normalized by tissue weight, centrifuged at 12,000g for 10 min and the supernatant was collected as the NP-40S fraction. The pellet was then resuspended in 1× SDS sample buffer with the volume normalized to initial tissue weight, heated at 95 • C for 30 min and collected as the NP-40P fraction.
RNA extraction, RT-PCR for Xbp1 mRNA splicing and qPCR. Total RNA was extracted from mouse tissues and cells using the Trizol and RNA miniprep kit (Sigma RTN350) with DNaseI digestion (New England Biolabs). RNA quality was determined by measuring the OD 260 nm/280 nm and visualized on an agarose gel. RT-PCR were performed as previously described 27 . The percentage of Xbp1 mRNA splicing defined as the ratio of Xbp1s level to total Xbp1(Xbp1u+Xbp1s) levels was quantified using the ImageLab software. All qPCR data for mouse tissues and cells were normalized to the ribosomal l32 gene in the corresponding sample. qPCR primer sequences (forward, reverse) are: (mouse genes if not specified), Ire1a Supplementary Fig. 9 . week-old mice were injected intraperitoneally with 30 mg/kg SP600125 (SP) every other day with concurrent treatment of 3% DSS for 5 days followed by fresh water: body weight change (d), colon length (e) and representative H&E images of colon at day 7 (f Supplementary Figure 9 continued 
